Gemcitabine, oxaliplatin and weekly high-dose 5-FU as 24-h infusion in chemonaive patients with advanced or metastatic pancreatic adenocarcinoma: a multicenter phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
暂无分享,去创建一个
A. Wein | W. Fleig | G. Kleber | M. Moehler | O. Kuss | A. Wagner | R. Behrens | U. Lindig | H. Schmalenberg | P. Buechner-Steudel